The survival of any microbe relies upon its ability to respond to environmental change. Use 16 of Extra Cytoplasmic Function (ECF) RNA polymerase sigma (σ) factors is a major strategy enabling 17 such signal transduction. Streptomyces species harbour a large number of ECF σ factors; nearly all 18 of which regulate genes required for morphological differentiation and/or response to environmental 19 stress, except for σ AntA , which regulates starter-unit biosynthesis in the production of antimycin, an 20 anticancer compound. Unlike a canonical ECF σ factor, whose activity is regulated by a cognate anti-21 σ factor, σ AntA is an orphan, raising intriguing questions about how its activity may be controlled. 22
Here, we reconstitute in vitro ClpXP proteolysis of σ AntA , but not a variant lacking a C-terminal di-23 alanine motif. Furthermore, we show that the abundance of σ AntA in vivo is enhanced by removal of 24 the ClpXP recognition sequence, and that levels of the protein rise when cellular ClpP-protease 25 activity is abolished. These data establish direct proteolysis as an alternative and thus far unique 26 control strategy for an ECF RNA polymerase σ factor and expands the paradigmatic understanding 27 of microbial signal transduction regulation. 28 29 Importance 30
Most antibiotics are derived from secondary metabolites produced by Streptomyces species. 31
The recent rise in the number of bacterial infections resistant to antibiotics has led to renewed interest 32 in discovery of new secondary metabolites produced by these microbes. An average species of 33
Streptomyces harbours ~30 biosynthetic pathways, but the majority of them are not in the laboratory. 34
Introduction 40
The survival of any organism relies upon its ability to respond to environmental change. This 41 feature is especially true of bacteria, which often live in hostile and fluctuating environments . 42 Streptomyces bacteria thrive in soils. The success of this genus of filamentous, sporulating bacteria 43 is linked to their complex lifecycle and keen ability to sense and respond to its surroundings. Notably, 44 a multitude of bioactive secondary or specialised metabolites are produced in response to 45 environmental cues 1 . More than half of all small molecule therapeutics critical for human health and 46 wellbeing are derived from or inspired by Streptomyces natural products 2 . 47
Streptomyces species typically harbor a large number of biosynthetic pathways, but only a 48 few of them are expressed under common laboratory conditions. The biochemical diversity encoded 49 by these silent pathways is a tremendous untapped resource for discovery of new antibacterial agents 50 and other therapeutics. All data available indicates that the production of natural products is 51 controlled predominantly at the level of transcription. Although there are complex regulatory 52 cascades that tightly control expression of biosynthetic genes, they are ultimately activated, repressed 53 or de-repressed by so-called cluster-situated regulators-regulatory protein(s) encoded within the 54 biosynthetic gene cluster (BGC) 3, 4 . Major roadblocks preventing the exploitation of silent 55 biosynthetic pathways are a lack of insight into their regulation and limited technology for activating 56 their expression. 57
Antimycins have been known for 70 years and are the foundering member of a large class of 58 natural products widely produced by Streptomyces species 5,6 . Recently, antimycins were shown to be 59 potent and selective inhibitors of the mitochondrial Bcl-2/Bcl-X L -related antiapoptotic proteins that 60 are overproduced by cancer cells and confer resistance to chemotherapeutic agents whose mode of 61 action is activation of apoptosis 7 . The ~25 kb antimycin (ant) BGC harboured by S. albus is composed 62 of 15 genes organised into four polycistronic operons antAB, antCDE, antFG and antHIJKLMNO 63 ( Fig. 1) 8, 9 . The regulation of this ant BGC is unusual compared to other secondary metabolites. Its 64 expression is regulated by FscRI, a cluster-situated LuxR-family regulator of candicidin biosynthesis; 65 FscRI activates expression of antAB and antCDE 10 . Importantly, antA is a cluster-situated regulator 66 that encodes an Extra Cytoplasmic Function (ECF) RNA polymerase σ factor (σ AntA ) that activates 67 expression of the remaining operons: antGF and antHIJKLMNO (Fig. 1 A 3 , R 1 = COCH 2 CH(CH 3 ) 2 , R 2 = (CH 2 ) 2 CH 3 ; Antimycin A 4 , R 1 = COCH(CH 3 ) 2 , R 2 = (CH 2 ) 2 CH 3 . 74 75 76 σ AntA , like all ECF σ factors, is similar to the housekeeping σ 70 family, but only possesses two 77 of the four highly characteristic sigma domains: domains σ2 and σ4; these regions of sigma bind the 78 -10 and -35 promoter elements, respectively and are sufficient for recruitment of RNA polymerase 11 . 79
Genes encoding ECF σ factors are almost always co-transcribed with their cognate anti-σ factor 12 . 80
This class of anti-σ factors are transmembrane proteins that selectively bind to and inactivate a partner 81 σ factor until its release is stimulated, usually by an exogenous signal 12,13 . After the σ factor is released 82 it recruits RNA polymerase to express a defined regulon that usually includes the σ factor-anti-σ 83 factor operon itself, which thus establishes a positive auto-feedback loop in the presence of the 84 inducing stimulus. Streptomyces species encode a large number of ECF σ factors (>30 per strain) and 85 nearly all of these regulate genes required for morphological differentiation and/or response to 86 environmental stress and, in contrast to σ AntA , are not dedicated regulators of one biosynthetic 87 pathway 9 . In addition, unlike the canonical ECF σ factors, whose activities are controlled by cognate 88 anti-σ factors, σ AntA appears to be an "orphan", lacking such a regulatory partner protein and thus has 89 created curiosity about how its activity is controlled. 90
The Clp-protease system is essential for normal bacterial proteostasis and is best characterised 91 in Escherichia coli 14, 15 . The Clp protease is a multi-enzyme complex composed of a barrel-shaped 92 peptidase, ClpP and a regulatory enzyme, either ClpA or ClpX (or ClpC in some organisms). ClpA 93 and ClpX (and ClpC) are all AAA+-family protein unfoldases that recognise an N-and/or C-terminal 94 recognition signal (degron) and utilise ATP to unfold and translocate proteins to the peptidase 95 chamber where they are degraded into short peptides 16 . In Streptomyces species, the peptidase is 96 specified by two genes instead of one and is redundantly encoded 17 . The primary peptidase is encoded 97 by clpP1P2, whose corresponding proteins form a complex with ClpX or ClpA to facilitate normal 98 proteostasis; the second peptidase is encoded by clpP3P4, but its expression only occurs when the 99 primary system is compromised 18, 19 . The best understood degron is the SsrA tag from E. coli 100 (AANDENYALAA), which is added co-translationally to polypeptides stalled on ribosomes 20,21 . The 101 E. coli SsrA tag has been comprehensively studied and the C-terminal Ala-Ala-COOof this motif is 102 essential for proteolysis by ClpXP 22 . Intriguingly, the C-terminus of σ AntA harbours the sequence Ala-103
Ala-COO -, which previously led us to speculate that ClpXP may modulate its level/activity 9 . 104
Here, we reconstitute ClpXP proteolysis of σ AntA in vitro and show that it is dependent upon 105 the C-terminal Ala-Ala. We also show that the abundance of σ AntA in vivo is higher when Ala-Ala is 106 changed to Asp-Asp and that abundance σ AntA is elevated in the absence of genes encoding the 107 primary peptidase, ClpP and its unfoldases, ClpA and ClpX. These data establish direct proteolysis 108 as an alternative, and thus far unique, control strategy of ECF RNA polymerase σ factors, expanding 109 the paradigmatic understanding of microbial signal transduction regulation. 110
Results 111 σ AntA orthologues are a new subfamily of ECF σ factor that regulate production of the 112 antimycin biosynthetic starter unit. Since its initial discovery six years ago, more than 70 ant BGCs 113 have been identified within actinomycete genera, including in Actinobacteria, Actinospica, 114
Saccharopolyspora, Streptacidiphilus and Streptomyces 5 . Each of these BGCs harbours a single 115 regulator, σ AntA (53-100% shared amino acid identity across all orthologues), which lacks a cognate 116 anti-σ factor partner 5,9 . Our previous work with S. albus S4 established that σ AntA orthologues 117 comprise a new subfamily of ECF σ factors 9,23 . We demonstrated σ AntA is required for expression of 118 antFG and antHIJKLMNO, which encode a standalone ketoreductase (AntM) and proteins required 119 for the production/activation of the starter unit, 3-formamidosalicylate (3-FSA) ( Fig. 1 ). We also 120 mapped the transcriptional start sites and identified conserved promoter sequences for these operons 121 in all known antimycin BGCs at the time 9 . The conservation of σ AntA and target promoters within ant 122
BGCs from taxonomically diverse species, suggests that σ AntA -mediated regulation of these genes is 123 direct. To verify this hypothesis, we performed ChIP-sequencing with a S. albus S4 ∆antA mutant 124 complemented with an N-terminal 3xFLAG-tagged version of σ AntA . The number of reads that 125 mapped to the promoters of antGF and antHIJKLMNO was enriched for both biological replicates of 126 ∆antA/3xFLAG-antA compared to that of the wild-type mock-immunoprecipitated control, indicating 127 that σ AntA directly activates the production of the 3-FSA starter unit during antimycin biosynthesis 128 17h) of the parent and ∆clpXclpP1clpP2 strains (Fig. 4) . Strikingly, 3xFLAG-σ AntA and 3xFLAG-182 σ AntA-DD could only be detected in extracts from aerial mycelia (24h and 30h) of the ∆clpXclpP1clpP2 183 strain and not the parent; the Asp-Asp variant was also present in greater relative abundance (Fig. 4) . 184
These data support the hypothesis that σ AntA levels, and thus its ability to activate gene expression is 185 modulated by the ClpXP protease, however the conspicuous absence of 3xFLAG-σ AntA shown in Supplementary Fig. 4 . 208
Discussion 209 ECF σ factors are a major component of bacterial signal transduction, are typically involved 210 in responding to external stimuli and their activity is canonically understood to be controlled via a 211 cognate anti-σ factor protein; the anti-σ is usually membrane bound and almost always encoded at 212 the same locus 12 . In this study, we characterised in vitro and in vivo, an ECF σ factor named σ AntA 213 that does not possess any identifiable anti-σ factor partner and as a consequence has evolved a 214 different mechanism of regulation. 215
We established that σ AntA is a cluster-situated regulator of antimycin biosynthesis and showed 216 by ChIP-sequencing that it directly binds upstream of genes required for 3-FSA production. Although 217 abundant within Streptomyces species, the activity of ECF σ factors that have been characterised are 218 involved in responding to environmental stress and/or regulating morphological differentiation. To 219 our knowledge, σ AntA is the only ECF σ factor that is a cluster-situated regulator in the genus 220
Streptomyces. Indeed, cluster-situated ECF σ factors have only thus far been observed within BGCs 221 for lantibiotics produced by so-called rare actinomycetes and these are controlled by anti-σ factors. 222
In Microbospora corallina, MibR and σ MibX regulate microbisporicin biosynthesis and σ MibX is 223 controlled by the anti-σ factor, MibW 27 ; in Planomonospora alba, PspR and σ PspX regulate 224 planosporicin production and σ PspX is controlled by the anti-σ factor, PspW 28 . 225
The C-terminal Ala-Ala present within σ AntA orthologues served as a clue that instead of an 226 anti-σ factor that ClpXP may regulate σ AntA activity. We unambiguously demonstrated that ClpXP 227 degraded σ AntA in vitro, but not an altered σ AntA variant in which Ala-Ala was changed to Asp-Asp. 228
We also assessed the level of σ AntA in vivo and showed that it was more abundant within vegetative 229 mycelia than in aerial mycelia and was partially stabilised by the Asp-Asp mutation, which was 230 consistent with our previous experiments that showed the ant BGC is downregulated at the level of 231 transcription upon the onset of aerial growth 9 . We demonstrated that the abundance of σ AntA and the 232 Asp-Asp variant was higher in vivo in a ∆clpXclpP1clpP2 mutant strain and further so when clpA 233 (orthologous to SCO7532 (clpC2)) was deleted. It was surprising that the Asp-Asp mutation did not 234 fully protect σ AntA from proteolysis in vivo, however enhanced abundance of σ AntA-DD in 235 ∆clpXclpP1clpP2 and ∆clpXclpP1clpP2clpA genetic backgrounds relative to the parent strain is 236 consistent with previous studies indicating N-terminal and internal motifs can also be important for 237 substrate recognition by Clp-proteases 26,29 . However, involvement of another protease, such as Lon, 238 in the degradation σ AntA cannot be excluded. 239
Direct ClpXP or ClpAP proteolysis of an ECF σ factor, as shown here, has not been reported 240 previously. However, it has been linked to ECF σ factors in the past, where proteolysis of σ S in E. when FscRI is inactivated following the onset of morphological differentiation 10 . The above model 255 ( Supplementary Fig. 5 ) is intriguing and begs the question why is it important for σ AntA to be actively 256 cleared from cell? One possibility is that aberrant/excess production of 3-FSA is cytotoxic, however 257 previous experiments in which the antA gene was artificially overexpressed did not adversely impact 258 growth of the organism 9 . An alternative hypothesis for why σ AntA must be rapidly removed from the 259 cell is to prevent unnecessary consumption of L-Trp. Biosynthesis of L-Trp is biologically expensive 260 and it is the most chemically complex and least abundant of the 20 common proteinogenic amino 261 acids 39 . It is tempting to speculate that the evolutionary rationale underpinning this regulatory strategy 262 is owed to the cell needing to dedicate more of this amino acid to production of proteins or metabolites 263 involved in development. This is consistent with recent data showing that deletion of trpM, which 264 controls precursor availability for L-Trp biosynthesis in S. coelicolor and presumably all 265 streptomycetes, fails to undergo normal morphological development 40 . 266
In conclusion, here we establish direct proteolysis by the Clp-protease system as an alternative 267 control strategy for ECF σ factors, which provides a new lens through which to examine microbial 268 signal transduction and the regulation of natural product biosynthesis in Streptomyces species. 269
Understanding the diversity of regulatory strategies controlling the expression of these pathways is 270 critical for the development of new tools for exploiting the 'silent majority' of biosynthetic pathways 271 harboured by these organisms. 272
Materials and methods 273
Growth media, strains, cosmids, plasmids, and other reagents. Escherichia coli strains 274 were propagated on Lennox agar (LA) or broth (LB) 41, 42 and Streptomyces albus S4 strains were 275 cultivated using LA, LB, and mannitol-soya flour (MS) agar or broth 41 . Development of clp mutants 276 was assessed on MS and ISP2 medium 41 . Culture medium was supplemented with antibiotics as 277 required at the following concentrations: apramycin, 50 μg/ml; carbenicillin, 100 μg/ml; 278 chloramphenicol, 25 μg/ml; hygromycin, 50 μg/ml; kanamycin, 50 μg/ml; nalidixic acid, 25 μg/ml. 279
Streptomyces strains were constructed by conjugal mating with E. coli ET12567 as previously 280 described 41 . Enzymes were purchased from New England BioLabs unless otherwise stated, and 281 oligonucleotides were purchased from Integrated DNA Technologies, Inc. All of the strains, cosmids, 282 and plasmids used in this study are described in Supplementary Table 1 , and all of the 283 oligonucleotides used are provided in Supplementary Table 2 . 284
Construction of plasmids. The insert for each plasmid generated in this study was prepared 285 by PCR amplification with Q5 High-Fidelity DNA polymerase and oligonucleotides containing 286 restriction sites. PCR-amplified inserts were restricted and cloned into the relevant plasmids cut with 287 the same enzymes by standard molecular biology procedures. All clones were sequenced to verify 288 the integrity of insert DNA. The restriction sites used for cloning are provided with the plasmid 289 descriptions in Supplementary Table 1 . 290
ChIP-sequencing and bioinformatics analyses. The antA coding sequence was amplified 291 with RFS629 and RFS630, which contain KpnI and EcoRI restriction sites, respectively. The 292 restricted PCR product was cloned into pSETNFLAG digested with the same enzymes. The resulting 293 plasmid was then restricted with NotI and EcoRI to release ermE*p-3xFLAG-antA, which was 294 subsequently cloned into pAU3-45 digested with the same enzymes. pAU3-45-3xFLAG-antA was 295 mobilised to an apramycin-marked ∆antA strain 9 . Cultivation of the wild-type and 296 ∆antA/pAUNFLAG-antA strains for ChIP-sequencing were performed exactly as described 297 previously 10 . The pure DNA resulting from immunoprecipitates from two biological replicates of 298 wild-type and ∆antA/pAUNFLAG-antA, as well non-immunoprecipitated chromosomal DNA, were 299 sequenced with the Illumina HiSeq3000 platform with 150-nucleotide paired-end reads by the 300 University of Leeds Next Generation Sequencing Facility at the St. James Teaching Hospital NHS 301
Trust. The resulting reads were analysed exactly as described previously 10 . The graphic in Figure 2 Supplementary Table 2 . The resulting PCR products were 314 digested with DpnI, gel purified and electroporated into arabinose-induced E. coli GB05-red 315 harbouring cos117 or cos251. Transformants were screened for the presence of mutagenised cosmid 316 by PCR using oligonucleotides listed in Supplementary Table 2 and the integrity of the locus was 317 verified by DNA sequencing. Mutagenised cosmids were electroporated into E. coli 318 ET12567/pUZ8002 and mobilised to a strain of S. albus S4 harbouring an entire antimycin BGC 319 deletion (∆antall) by conjugation as described 41 . Transconjugants were screened for apramycin 320 resistance and kanamycin sensitivity. The integrity of apramycin-marked mutants was verified by 321 PCR using the oligonucleotides listed in Supplementary Table 2 . The apramycin deletion cassette 322 was subsequently excised from the chromosome by conjugal introduction of pUWLint31, which is a 323 replicative plasmid with a temperature sensitive origin of replication that expresses the ΦC31 324 integrase required for removal of the cassette 45 . Transconjugants were screened for loss of apramycin 325 resistance and excision of the cassette was verified by polymorphic shift PCR and DNA sequencing 326 of the product. 327
Immunoblot analysis. Spores of parental strain, S. albus ∆antall, ΔclpXclpP1clpP2 and 328 ΔclpXclpP1clpP2clpA mutants carrying pPDA or pPDD were grown on SFM agar (buffered with 329 50mM TES, pH 7.2) covered with cellophane discs. Protein extracts were prepared from mycelia 330 collected at regular intervals during growth (14h, 17h, 24h and 30h) as follows: 100 mg of cells were 331 resuspended in 200 μl lysis buffer (50 mM sodium phosphate buffer, pH 7.0, 150 mM sodium 332 chloride, 10 mg/ml lysozyme, cOmplete, Mini, EDTA-free protease inhibitors (Roche) and 100 mg 333 of 0.1 mm glass beads (PowerLyzer®)) and lysed by vortexing for 30 min at 2000 pm, 37°C, with a 334 subsequent incubation for another 30 min at 37°C. The obtained suspension was centrifuged for 20 335 min at 20,000g at 18°C. Thirty micrograms of the clarified protein extract were subjected to SDS-336 PAGE and then transferred to nitrocellulose membrane (pore size 0.2 μm) for Western blot analysis. 337
The membrane was probed with mouse monoclonal ANTI-FLAG® M2-Peroxidase (HRP) antibody 338 (Sigma), 1:10 000, and the signals were detected using Pierce TM 1-Step Ultra TMB Blotting Solution 339 (Thermo Scientific). 340
Protein purification and in vitro ClpXP proteolysis assays. The wild-type antA gene was 341 PCR amplified and cloned into the AgeI and HindIII sites of the pET23b-SUMO vector, which 342 harbours an N-terminal (His)6-SUMO tag 46 . The plasmid for production of (His)6-SUMO-σ AntA-DD 343 was generated by site-directed mutagenesis (Agilent QuikChange) using primers listed in 344 Supplementary Table 2 . (His)6-SUMO-σ AntA and (His)6-SUMO-σ AntA-DD were produced by E. coli 345 Rosetta(DE3) (Novagen) grown in LB at 37 °C until OD600 0.5, followed by induction with 0.4 mM 346 IPTG and growth at 18 °C for 16 hours. Cells were resuspended in 50 mM sodium phosphate, pH 8, 347 1M NaCl, 20 mM imidazole, 10% glycerol, and 1 mM DTT and lysed by french press at 28 kpsi, 348 followed by treatment with protease inhibitor cocktail set III, EDTA-free (Calbiochem) and 349 benzonase (Millipore Sigma). (His)6-SUMO-σ AntA and (His)6-SUMO-σ AntA-DD proteins were purified 350 by Ni-NTA affinity chromatography and Superdex-75 gel filtration and stored in 50 mM potassium 351 phosphate, pH 6.8, 850 mM KCl, 10% glycerol, and 1 mM DTT. E. coli ClpX and ClpP proteins 352 were purified as described previously 46,47 . 353 In vitro ClpXP proteolysis assays were performed at 30 °C by preincubating 0. 
